XML 38 R26.htm IDEA: XBRL DOCUMENT
v3.21.2

Shareholders' Equity (Tables) | 9 Months Ended
--- | ---
Oct. 03, 2021
Equity [Abstract] |
Earnings (Loss) per share | The following table sets forth the computation of basic and diluted earnings/(loss) per share:
|  | Three Months Ended |  | Nine Months Ended
|  | October 3, 2021 |  | September 27, 2020 |  | October 3, 2021 |  | September 27, 2020
Numerator: |  |  |  |  |  |  |  |
Net income/(loss) attributable to Sonoco |  | $ | 111,140 |  |  | $ | 83,449 |  |  | $ | (150,634) |  |  | $ | 219,105 |
Denominator: |  |  |  |  |  |  |  |
Weighted average common shares outstanding: |  |  |  |  |  |  |  |
Basic |  | 98,955 |  |  | 100,974 |  |  | 100,039 |  |  | 100,935 |
Dilutive effect of stock-based compensation |  | 470 |  |  | 271 |  |  | — |  |  | 220 |
Diluted |  | 99,425 |  |  | 101,245 |  |  | 100,039 |  |  | 101,155 |
Net income/(loss) attributable to Sonoco per common share: |  |  |  |  |  |  |  |
Basic |  | $ | 1.12 |  |  | $ | 0.83 |  |  | $ | (1.51) |  |  | $ | 2.17 |
Diluted |  | $ | 1.12 |  |  | $ | 0.82 |  |  | $ | (1.51) |  |  | $ | 2.17 |
Cash dividends |  | $ | 0.45 |  |  | $ | 0.43 |  |  | $ | 1.35 |  |  | $ | 1.29 |
Schedule of antidilutive securities excluded from computation of earnings per share | The average numbers of SARs that were anti-dilutive and, therefore, not included in the computation of diluted earnings per share during the three- and nine-month periods ended October 3, 2021 and September 27, 2020 were as follows:
|  | Three Months Ended |  | Nine Months Ended
|  | October 3, 2021 |  | September 27, 2020 |  | October 3, 2021 |  | September 27, 2020
Anti-dilutive stock appreciation rights |  | — |  |  | 752 |  |  | 142 |  |  | 844 |
The following table sets forth the potentially dilutive securities excluded from the computation of diluted net loss per share during the nine-month period ended October 3, 2021:
|  | Nine Months Ended |
|  | October 3, 2021 |
Dilutive securities excluded due to reported loss |  | 469 |  |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration